OncLive TV

Dr. Gordon Mills from MD Anderson Cancer Center Gives Examples of Unexpected Therapy Responses

Dr. Giorgio Scagliotti from the University of Turin Gives 3 Important Lung Cancer Takeaway Points

Dr. Pramod Mistry from Yale University School of Medicine on Gaucher Disease Entering a New Era

Dr. Lori Goldstein from Fox Chase Cancer Center on Fulvestrant in Metastatic Breast Cancer

Dr. Rex Yung from Sidney Kimmel Comprehensive Cancer Center on a Paradigm Shift in Lung Cancer Treatment

Dr. Wayne Bardwell from UCSD Cancer Center on Cancer-Related Variables and Depression

Dr. Teresa Woodruff from the Oncofertility Consortium on the Patient Navigator's Role in Oncofertility

Dr. Gregory A. Grabowski from Cincinnati Children's Hospital Medical Center Explains the Effects of Enzyme Therapy

Dr. Rogerio Vivaldi the President of Genzyme Corporation on the Transformation of Gaucher Disease

Dr. Pramod Mistry from the Yale University School of Medicine Explains the History of Gaucher Disease

Dr. Richard Moscicki from Chief Medical Officer, Genzyme Corporation, on His Experience With Lysosomal Diseases

Dr. Harold P. Freeman from Ralph Lauren Center for Cancer Care and Prevention Describes Patient Navigation

Dr. Wayne Bardwell from the UCSD Cancer Center Discusses Psychosocial Needs of Cancer Patients

Dr. Teresa Woodruff from Feinberg School of Medicine, Northwestern University Discusses the Growing Field of Oncofertility

Dr. Giorgio Scagliotti from University of Turin Discusses Elderly Lung Cancer Therapy

Dr. Gordon B. Mills from the University of Texas MD Anderson Cancer Center Discusses the Field of Targeted Therapeutics

Dr. Heather Wakelee from the Stanford Clinical Cancer Center on the Future of Lung Cancer Adjuvant Therapy

Dr. Hope S. Rugo from the University of California, San Francisco on the Efficacy of Bevacizumab in Breast Cancer

Dr. Rex Yung from Sidney Kimmel Comprehensive Cancer Center Discusses the Evolving Role of the Pulmonologist

Dr. Andre Goy from John Theurer Cancer Center Highlights Recent Advances in Oncology

Dr. Corey Langer from Abramson Cancer Center on Cost Analysis in the Treatment Decision

Dr. Luisa Iruela-Arispe from University of California, Los Angeles on the Dr. Paul Janssen Award Symposium

Dr. Giorgio Scagliotti from the University of Turin Discusses the Future of Multiple Gene Profiles

Dr. Andre Goy from John Theurer Cancer Center on Integrating Novel Therapies Into the JTCC Conference

Dr. Monica Morrow from Memorial Sloan-Kettering Cancer Center Discusses the Z11 Trial Focus on Morbidity

Dr. Debu Tripathy from USC Norris Comprehensive Cancer Center Discusses Iniparib Trial Heterogeneity

Dr. Andre Goy from John Theurer Cancer Center on the Upcoming Conference at John Theurer Cancer Center

Dr. Heather Wakelee from Stanford Clinical Cancer Center on Using Lymph Nodes for Lung Cancer Staging

Dr. Giorgio V. Scagliotti from the University of Turin on Mechanisms of Resistance to EGFR TKIs

Dr. Gordon B. Mills from MD Anderson Cancer Center Discusses the Development of Combination Therapies